Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Pfizer ups offer for AstraZeneca to $84.19 per share; AZ board not interested

Executive Summary

After proposing to pay $78.48 (£46.61) back in January, Pfizer Inc. upped its offer for AstraZeneca PLC to $84.19 per share--a 17% discount based on the original bid date and 43% based on the current market average--valuing the transaction at $106bn.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register